This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Screening test test dementia in people with hearing loss (hearing impairment or deafness)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Screening test test dementia in people with hearing loss

  • more than 3 in 4 people aged over 75 years have hearing problems - thus any people with dementia also have hearing loss (1)

  • Montreal Cognitive Assessment (MoCA) is commonly used to diagnose cognitive impairment or dementia

    • a validated, sensitive and reliable cognitive test for people with hearing problems and is now available for use
      • adapted existing MoCA items for people with hearing impairment by presenting instructions and stimuli in written rather than spoken format (MoCA-H)

      • closely matches the standard test for identifying dementia in people with hearing loss

      • asks similar questions, takes a similar length of time to complete and assesses the same cognitive areas

      • MoCA-H tool is available from https://mocacognition.com/

      • MoCA-H is a sensitive and reliable means of identifying dementia among adults with acquired hearing impairment.

Reference:

  • Dawes, P, Reeves, D, Yeung, WK, et al. Development and validation of the Montreal cognitive assessment for people with hearing impairment (MoCA-H). J Am Geriatr Soc. 2023; 71(5): 1485-1494. doi:10.1111/jgs.18241

 

 

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.